HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Linsidomine

HCID 5219
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
33876-97-0
Standard SMILES
N=c1c[n+](N2CCOCC2)[n-]o1
InChIKey
FKDHHVKWGRFRTG-UHFFFAOYSA-N
Molecular formula
C6H10N4O2
Average molar mass
170.17 g/mol
Monoisotopic mass
170.08037557

Overview

Linsidomine is a member of morpholines.

Names & identifiers

Preferred name
Linsidomine
IUPAC
3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine
English name
3-Morpholinosydnonimine
Molecular formula
C6H10N4O2
Molecular weight
170.17

Names & synonyms

Linsidomine33876-97-03-Morpholinosydnone imineLinsidominaLinsidominumsin-13-MorpholinosydnoneimineCV 6645O5U71P6VQDTXSID501026026N-morpholino sydnonimine3-Morpholino-sydnonimine
Show more names
cv6643-MorpholinosydnonmineHCl3-Morpholinosydnone imine-3-ium3-MorpholinosydnonminehydrochlorideMolsidomine EP Impurity A(linsidomine)Molsidomine Impurity 1 (Molsidomine EP Impurity A)3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine
SIN-1 morpholineCV-6643-morpholinosydonimineRefChem:153577C01DX18DTXCID4015102745-azanidyl-3-(morpholin-4-yl)-1,2,3lambda5-oxadiazol-3-ylium3-MORPHOLINOSYDNONIMINE

Database identifiers

CAS
33876-97-0
PubChem CID
5219
DTXSID
DTXSID501026026
ChEMBL
CHEMBL1189150

Properties

Computed structural properties

XLogP
0.6
Topological polar surface area
49.6 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
5
Rotatable bonds
1
Heavy atoms
12
Formal charge
0
Complexity
222

Physicochemical properties

storage temp.
20 °C · −20°C
solubility
2 O: · H2O: >10 mg/mL
form
solid
color
off-white
FDA UNII
5 O5U71P6VQ · 5O5U71P6VQ
WGK Germany
3 · 3
HS Code
2934999090 · 2934999090

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
3
hs_code
2934999090

Chemistry & industry

Pharmacology

ATC Code · 2 items

C - Cardiovascular system

QC - Cardiovascular system

MeSH Pharmacological Classification · 5 items

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

Drugs used to cause dilation of the blood vessels.

A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81)

Applications

Uses3-Morpholinosydnonimine is a potent vasodilator that inhibits platelet aggregation and cysteine proteases.

Additional notes

DefinitionChEBI: Linsidomine is a member of morpholines.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
ChEBI
CHEBI:136004
UNII
5O5U71P6VQ
Nikkaji
J314.096B